arrow_back Trending Legislation
Share share

Infant Formula Safety Modernization Act of 2026

This act introduces stricter controls and mandatory bacterial testing for infant formula products. It aims to ensure that formula sold in stores is safe for babies by requiring faster reporting of contamination.
Key points
Mandatory testing of finished formula and production facilities for dangerous pathogens.
Manufacturers must report any positive test results for bacteria within one business day.
Consistent safety and inspection standards for both domestic and imported infant formula.
Fast-tracked notification to Congress regarding safety issues or failed facility inspections.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Introduced
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Infant Formula Safety Modernization Act of 2026
Print number: HR 7867
Sponsor: Rep. DeLauro, Rosa L. [D-CT-3]
Process start date: 2026-03-09
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-flash-latest
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Infant Formula Safety Modernization Act of 2026

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 7867.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2026-03-09.

What are the main provisions?

Key points include:

  • Mandatory testing of finished formula and production facilities for dangerous pathogens.
  • Manufacturers must report any positive test results for bacteria within one business day.
  • Consistent safety and inspection standards for both domestic and imported infant formula.
  • Fast-tracked notification to Congress regarding safety issues or failed facility inspections.

What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. DeLauro, Rosa L. [D-CT-3].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2026-03-27.

Analysis and Potential Impact of HR 7867

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health Family